Short Steroid Taper Tested With Tocilizumab for GCA

Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce patients' duration of exposure to glucocorticoids.

Related Keywords

Massachusetts ,United States ,Boston ,Sebastian Unizony ,Harvard Medical School ,Vasculitis ,Temporal Arteritis ,Giant Cell Arteritis ,Steroids ,Blood Vessels ,Glucocorticosteroids ,Rheumatoid Arthritis ,A ,Geriatrics Elder Care ,Elderly Concerns Of Older Adults ,Clinical Research ,Clinical Trials ,Linical Studies ,